David Grossman
Stock Analyst at Stifel
(3.78)
# 660
Out of 4,784 analysts
159
Total ratings
56.36%
Success rate
4.98%
Average return
Main Sectors:
Stocks Rated by David Grossman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRIO DarioHealth | Maintains: Buy | $3.5 → $2 | $0.62 | +221.03% | 4 | Mar 11, 2025 | |
| DCGO DocGo | Maintains: Buy | $6.5 → $5.5 | $2.64 | +108.33% | 9 | Feb 28, 2025 | |
| HCAT Health Catalyst | Maintains: Hold | $10 → $5 | $4.55 | +9.89% | 5 | Feb 27, 2025 | |
| EXLS ExlService Holdings | Maintains: Buy | $48 → $54 | $46.80 | +15.38% | 1 | Feb 27, 2025 | |
| ACN Accenture | Maintains: Buy | $390 → $380 | $304.33 | +24.86% | 26 | Feb 26, 2025 | |
| AMWL American Well | Maintains: Hold | $9 → $10 | $7.82 | +27.88% | 2 | Feb 13, 2025 | |
| ACCD Accolade | Downgrades: Hold | $8 → $7.03 | $6.99 | +0.57% | 6 | Jan 9, 2025 | |
| VEEV Veeva Systems | Maintains: Buy | $240 → $272 | $234.21 | +16.14% | 7 | Dec 6, 2024 | |
| OPRX OptimizeRx | Maintains: Buy | $13 → $8 | $8.64 | -7.41% | 6 | Nov 14, 2024 | |
| IBM International Business Machines | Maintains: Buy | $205 → $246 | $244.00 | +0.82% | 20 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $130 → $141 | $151.03 | -6.64% | 9 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $16 → $9 | $8.09 | +11.25% | 10 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $271 → $287 | $300.83 | -4.60% | 10 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $7.5 | $2.94 | +155.10% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $21 → $19 | $17.08 | +11.24% | 10 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $117 → $121 | $79.06 | +53.05% | 11 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $288 → $301 | $168.93 | +78.18% | 11 | Feb 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Positive | $22 → $29 | $18.17 | +59.60% | 9 | Jan 10, 2022 |
DarioHealth
Mar 11, 2025
Maintains: Buy
Price Target: $3.5 → $2
Current: $0.62
Upside: +221.03%
DocGo
Feb 28, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $2.64
Upside: +108.33%
Health Catalyst
Feb 27, 2025
Maintains: Hold
Price Target: $10 → $5
Current: $4.55
Upside: +9.89%
ExlService Holdings
Feb 27, 2025
Maintains: Buy
Price Target: $48 → $54
Current: $46.80
Upside: +15.38%
Accenture
Feb 26, 2025
Maintains: Buy
Price Target: $390 → $380
Current: $304.33
Upside: +24.86%
American Well
Feb 13, 2025
Maintains: Hold
Price Target: $9 → $10
Current: $7.82
Upside: +27.88%
Accolade
Jan 9, 2025
Downgrades: Hold
Price Target: $8 → $7.03
Current: $6.99
Upside: +0.57%
Veeva Systems
Dec 6, 2024
Maintains: Buy
Price Target: $240 → $272
Current: $234.21
Upside: +16.14%
OptimizeRx
Nov 14, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $8.64
Upside: -7.41%
International Business Machines
Oct 16, 2024
Maintains: Buy
Price Target: $205 → $246
Current: $244.00
Upside: +0.82%
Oct 2, 2024
Maintains: Hold
Price Target: $130 → $141
Current: $151.03
Upside: -6.64%
Aug 1, 2024
Maintains: Hold
Price Target: $16 → $9
Current: $8.09
Upside: +11.25%
Aug 1, 2024
Maintains: Hold
Price Target: $271 → $287
Current: $300.83
Upside: -4.60%
Jul 31, 2024
Maintains: Buy
Price Target: $9.5 → $7.5
Current: $2.94
Upside: +155.10%
May 17, 2024
Maintains: Hold
Price Target: $21 → $19
Current: $17.08
Upside: +11.24%
Feb 16, 2024
Maintains: Buy
Price Target: $117 → $121
Current: $79.06
Upside: +53.05%
Feb 12, 2024
Maintains: Buy
Price Target: $288 → $301
Current: $168.93
Upside: +78.18%
Jan 10, 2022
Upgrades: Positive
Price Target: $22 → $29
Current: $18.17
Upside: +59.60%